Edit |   |
---|---|
Antigenic Specificity | IL31RA, Human (Nemolizumab biosimilar) |
Clone | Nemolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG2 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, FCM, IP, IF, FuncS |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human IL31RA Recombinant Antibody. Nemolizumab is an experimental drug for the treatment of itching in people with atopic dermatitis. It is a monoclonal antibody that blocks the interleukin-31 receptor A. Results of a Phase II clinical trial were published in March 2017. |
Immunogen | n/a |
Other Names | Anti-IL31RA Recombinant Antibody, Research Grade Nemolizumab, Anti-Human IL31RA Recombinant Antibody, CIM 331, Antibody Drug Analogues, Monoclonal Antibody, YR1365, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1476039-58-3 |
Catalog # | YR1365 |
Price | please inquire |
Order / More Info | IL31RA, Human (Nemolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |